Hepatitis B prevention: Can we learn from the response to HIV/AIDS?

English version

Autoři: Mirjam E. E. Kretzschmar ^aff001; Marianne A. B. van der Sande ^aff001
Působiště autorů: Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands ^aff001; Centre for Infectious Disease Control, National Institute of Public Health and the Environment (RIVM), Bilthoven, The Netherlands ^aff002; Department Public Health, Institute of Tropical Medicine, Antwerp, Belgium ^aff003
Vyšlo v časopise: Hepatitis B prevention: Can we learn from the response to HIV/AIDS?. PLoS Med 17(4): e32767. doi:10.1371/journal.pmed.1003109
Kategorie: Perspective
doi: https://doi.org/10.1371/journal.pmed.1003109

Souhrn

Mirjam Kretzschmar and Marianne van der Sande discuss the accompanying research study by Anna McNaughton and colleagues on strategies to reduce the burden of hepatitis B in African countries.

Klíčová slova:

Africa – Hepatitis B – Hepatitis B virus – HIV – HIV prevention – Chronic hepatitis – Infants – Vaccination and immunization

Zdroje

1. Liang TJ. Hepatitis B: the virus and disease. Hepatology. 2009 May;49(5 Suppl):S13–21.

2. McNaughton AL, Lourenço J, Bester PA, Mokaya J, Lumley SF, Obolski U, et al. Hepatitis B virus seroepidemiology data for Africa: Modelling intervention strategies based on a systematic review and meta-analysis. PLoS Med. 2020;17(4):e1003068. doi: 10.1371/journal.pmed.1003068

3. McNaughton AL, Lourenço J, Hattingh L, Adland E, Daniels S, Van Zyl A, et al. HBV vaccination and PMTCT as elimination tools in the presence of HIV: insights from a clinical cohort and dynamic model. BMC Med. 2019 Feb 21;17(1):43. doi: 10.1186/s12916-019-1269-x 30786896

4. UNAIDS 2016–2021 Strategy. On the Fast-Track to end AIDS. https://www.unaids.org/sites/default/files/media_asset/20151027_UNAIDS_PCB37_15_18_EN_rev1.pdf

5. Medley GF, Lindop NA, Edmunds WJ, Nokes DJ. Hepatitis-B virus endemicity: heterogeneity, catastrophic dynamics and control. Nat Med. 2001 May;7(5):619–24. doi: 10.1038/87953 11329065

6. WHO Global Hepatitis Report 2017. Available from: http://apps.who.int/iris/bitstream/10665/255016/1/9789241565455-eng.pdf?ua=1. [cited 2020 March 27].

7. Miyahara R, Jasseh M, Gomez P, Shimakawa Y, Greenwood B, Keita K, et al. Barriers to timely administration of birth dose vaccines in The Gambia, West Africa. Vaccine. 2016 Jun 17;34(29):3335–41. doi: 10.1016/j.vaccine.2016.05.017 27195759

8. Lazarus JV, Lundgren J, Casabona J, Wiessing L, Matheï C, Vickerman P, et al. Roundtable discussion: how lessons learned from HIV can inform the global response to viral hepatitis. BMC Infect Dis. 2014;14 Suppl 6:S18. doi: 10.1186/1471-2334-14-S6-S18 25252919

9. Joint United Nations Programme on HIV/AIDS (UNAIDS). 90-90-90, An ambitious treatment target to help end the AIDS epidemic. 2014. https://www.unaids.org/sites/default/files/media_asset/90-90-90_en_0.pdf

10. Eisinger RW, Fauci AS. Ending the HIV/AIDS Pandemic. Emerg Infect Dis. 2018 Mar;24(3):413–416. doi: 10.3201/eid2403.171797 29460740

11. Abdool Karim SS. HIV-1 Epidemic Control—Insights from Test-and-Treat Trials. N Engl J Med. 2019 Jul 18;381(3):286–288. doi: 10.1056/NEJMe1907279 31314975

12. Nwokolo N, Hill A, McOwan A, Pozniak A. Rapidly declining HIV infection in MSM in central London. Lancet HIV. 2017 Nov;4(11):e482–e483. doi: 10.1016/S2352-3018(17)30181-9 29066095

13. Chevaliez S, Pawlotsky JM. New virological tools for screening, diagnosis and monitoring of hepatitis B and C in resource-limited settings. J Hepatol. 2018 Oct;69(4):916–926. doi: 10.1016/j.jhep.2018.05.017 29800630

14. Spearman CW, Afihene M, Ally R, Apica B, Awuku Y, Cunha L, et al. Hepatitis B in sub-Saharan Africa: strategies to achieve the 2030 elimination targets. Lancet Gastroenterol Hepatol. 2017 Dec;2(12):900–909. doi: 10.1016/S2468-1253(17)30295-9 29132759

Článek Effectiveness of the Common Elements Treatment Approach (CETA) in reducing intimate partner violence and hazardous alcohol use in Zambia (VATU): A randomized controlled trial

Článek HIV testing and treatment coverage achieved after 4 years across 14 urban and peri-urban communities in Zambia and South Africa: An analysis of findings from the HPTN 071 (PopART) trial

Článek Hepatitis B virus seroepidemiology data for Africa: Modelling intervention strategies based on a systematic review and meta-analysis

Článek Pre-exposure prophylaxis for preventing acquisition of HIV: A cross-sectional study of patients, prescribers, uptake, and spending in the United States, 2015–2016

Článek Adaptive guidelines for the treatment of gonorrhea to increase the effective life span of antibiotics among men who have sex with men in the United States: A mathematical modeling study

Článek CINeMA: An approach for assessing confidence in the results of a network meta-analysis

Článek Febuxostat does not delay progression of carotid atherosclerosis in patients with asymptomatic hyperuricemia: A randomized, controlled trial

Článek Metabolic risk factors and incident advanced liver disease in non-alcoholic fatty liver disease (NAFLD): A systematic review and meta-analysis of population-based observational studies

Článek Pandemic responses: Planning to neutralize SARS-CoV-2 and prepare for future outbreaks

Článek vyšel v časopise